415 PHT Plasma Level – Time Curve

Slides:



Advertisements
Similar presentations
Instant Clinical Pharmacology E.J. Begg
Advertisements

LAKSHMAN KARALLIEDDE OCTOBER 2011
PHARMACOKINETIC.
Pharmacokinetics Ampicillin Ceftriaxone Vancomycin Half-Life: hr
III. Drug Metabolism  The aim of drug metabolism is to convert lipid soluble (non polar) drugs to polar metabolites easily excreted in urine.  The liver.
Dose-Response Relationships Lesson 6. Dose & Drug Effects n Pharmacodynamics l what the drug does to the body n Effects of drug depends on dose n In general...
Pharmacokinetics -- part 1 --
Plasmids Chromosome Plasmid Plasmid + Transposon Plasmid + integron Plasmid+transposon +intergron Chromosome Chromosome + transposon Chromosome + transposon.
Selected bioavailability and pharmacokinetic calculations Dr. Osama A. A. Ahmed.
Pharmacokinetics of Drug Absorption
Week 5- Pharmacokinetics of oral absorption
How and Why Drugs Work Chapter 5
Practical Pharmacokinetics
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Toxicokinetic Calculations
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
Week 6- Bioavailability and Bioequivalence
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PHARMACOKINETICS 1. Fate of drugs in the body 1.1 absorption
Nonlinear Pharmacokinetics
Pharmacokinetics Introduction
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
Fundamentals of Drug Action
Bioavailability  The in- vitro methods of evaluating dosage forms provide only indirect evidence of the therapeutic utility of the drug in a given dosage.
Bioavailability Dr Mohammad Issa.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
FARMAKOKINETIKA. INTRODUCTION Historically, pharmaceutical scientists have evaluated the relative drug availability to the body in vivo after giving a.
BASIC PHARMACOKINETIC PARAMETERS. PHARMACOKINETICS Pharmacokinetics is the study of the time course of a drug within the body and incorporates the processes.
Pharmacokinetics of Drug Absorption Prepared by: KAZI RASHIDUL AZAM.
1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following.
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
Core Concepts in Pharmacology Chapter 5 Pharmacokinetics.
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas.
The General Concepts of Pharmacokinetics and Pharmacodynamics
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
Bioavailability Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.
BASIC BIOPHARMACEUTICS
INTRODUCTION CLINICAL PHARMACOKINETICS
BIOPHARMACEUTICS.
1 Pharmacokinetics: Introduction Dr Mohammad Issa.
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
Nonlinear Pharmacokinetics
© Paradigm Publishing, Inc.1 Chapter 2 Basic Concepts of Pharmacology.
Pharmacokinetics of Drug Absorption Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University.
Design of Sustained Release Dosage Forms
DEFINITIONS T1/2 & Tmax Cmax AUC 1st order kinetics
ــــــــــــــ February 17 th, PHT - LECTURE Mathematical Fundamental in Pharmacokinetics Dr. Ahmed Alalaiwe.
PHT 415 BASIC PHARMACOKINETICS
The General Concepts of Pharmacokinetics and Pharmacodynamics
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
Basic Concepts of Pharmacology © Paradigm Publishing, Inc.
Definitions and Concepts
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
MULTIPLE DOSAGE REGIMEN
Introduction to Biopharmaceutics and Pharmacokinetics
Drug Response Relationships
Chapter 8 BIOAVAILABILITY & BIOEQUIVALENCE
Applications of Pharmacokinetics
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Quantitative Pharmacokinetics
Clinical Pharmacokinetics
Clinical Pharmacokinetics
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
Basic Biopharmaceutics
Therapeutic Drug Monitoring chapter 1 part 1
Presentation transcript:

415 PHT Plasma Level – Time Curve Dr. Ahmed Alalaiwe a.alalaiwe@psau.edu.sa Office: 13A-1 Office Hours: Wed 01-03 pm 1437 - 2016

Objectives By the end of this lecture, you will be able to: Understand the concept of drug response relationships Define the major pharmacokinetic parameters related to plasma level curve Differentiate the plasma level curve profiles based on their expression

Drug Response Relationships Time Response Dose Response

Time Response Relationships Maximal (Peak) Effect Effect/ Response Latency Duration of Response Time

Time Response Relationships Effect/ Response Time

Dose Response Relationships Potency Absolute amount of drug required to produce an effect More potent drug is the one that requires lower dose to cause same effect. Efficacy is the maximal response produced by the drug.

Dose Response Relationships B Effect Dose A Therapeutic Effect Which drug has the lower threshold dose? Which has the greater maximum effect?

Plasma Level – Time Curve The plasma level–time curve is generated by obtaining the drug concentration in plasma samples taken at various time intervals after a drug product is administered. In general, serum or plasma is most commonly used for drug measurement Generalized plasma level–time curve after oral administration of a drug.

Plasma Level – Time Curve Generalized plasma level–time curve after oral administration of a drug

Plasma Level – Time Curve As the drug reaches the general (systemic) circulation, plasma drug concentrations will rise up to a maximum. Usually, absorption of a drug is more rapid than elimination As the drug is being absorbed into the systemic circulation, the drug is distributed to all the tissues in the body and is also simultaneously being eliminated Elimination of a drug can proceed by excretion, biotransformation, or a combination of both

Plasma Level – Time Curve The MEC (minimum effective concentration) reflects the minimum concentration of drug needed at the receptors to produce the desired pharmacologic effect The MTC (minimum toxic concentration) represents the drug concentration needed to just barely produce a toxic effect

Plasma Level – Time Curve The onset time corresponds to the time required for the drug to reach the MEC The intensity of the pharmacologic effect is proportional to the number of drug receptors occupied, which is reflected in the observation that higher plasma drug concentrations produce a greater pharmacologic response, up to a maximum The duration of drug action is the difference between the onset time and the time for the drug to decline back to the MEC

Plasma Level – Time Curve The time of peak plasma level is the time of maximum drug concentration in the plasma and is a rough marker of average rate of drug absorption The peak plasma level or maximum drug concentration is related to the dose, the rate constant for absorption, and the elimination constant of the drug The AUC is related to the amount of drug absorbed systemically Plasma level–time curve showing peak time and concentration. The shaded portion represents the AUC (area under the curve)

Plasma Level – Time Curve

Important parameters in bioavailability studies Time to Peak (Tmax): the time after admin that it takes for the drug to reach Cmax. This is an indication of the rate of absorption. Max. conc. Attained (Cmax): assesses whether concentration is in therapeutic range Area Under the Curve (AUC): Total drug absorption, reflects changes in distribution, metabolism & excretion Onset of Action: The time required to reach the MEC. following drug admin. Duration of Action: The time period in which the plasma conc. Exceeds MEC. Intensity: the difference in the MEC and Cmax.

Important parameters in bioavailability studies Absorption rate conctant (ka): assesses the rate of drug absorption from a formulation Minimum Effective Concentration (MEC): minimum plasma conc. that must be reached before achieving therapeutic effect. Maximum Safe Concentration (MSC): the conc. above which toxic effects are seen. Minimum Toxic Concentration (MTC): The minimum concentration at which the toxic effect of the drug is seen. Therapeutic Range: Plasma conc. range bet. MEC and MSC.

Blood Concentration-Time Profiles Minimum effective dose (MEC) Smallest concentration of the drug that is sufficient to cause an effect. Minimum Toxic Concentration (MTC): Smallest concentration beyond which the there are undesirable or toxic effect. Therapeutic window Range between MEC and MTC. Duration of action Time the drug should above the MEC.

Blood Concentration-Time Profiles

Blood Concentration-Time Profiles

Concentration vs Time Graph

Bioavailability - AUC AUC – area under the curve F – bioavailability AUC p.o. F = ------------ x 100% AUC i.v.

Bioavailability - AUC

Bioavailability - AUC